Cancer vaccine in 2030

Plus: NASA prepares to break the sound barrier with Lockheed Martin's X-59. Oct 18, 2022 [Blueprint]( Step aside COVID-19 vaccines, there’s a new headline-grabber in town. Because according to the founders of German company BioNTech, mRNA [vaccines that can help target cancer]( could be ready for use before the end of the decade. BioNTech has been working on mRNA technology to develop vaccines since its inception in 2008. And yes, in 2020, BioNTech pivoted its focus and used its technological know-how to develop a vaccine to protect us against the coronavirus. BioNTech has multiple cancer vaccine candidates in clinical trials and is hopeful that its COVID success will aid its cancer work. But before you feast your eyes on that, feast your eyes on [this video]( which explains why we’re getting fatter. Try not to take it personally. Good morning. I’m Alice, an Editor at IE. This is The Blueprint. Let’s get started. Last Sunday, Blueprint subscribers had an exclusive insight from scientists around the globe about whether coffee has many more (some fairly life-changing) health benefits than we realize. This week, they'll hear from the people behind the wearable tech that can charge your phone with 1,200 tiny solar panels. Don't miss out — [subscribe to IE+]( today to receive exclusive interviews, features, and much more. [Play]VIDEO OF THE DAY [This video explains why we’re getting fatter.]( [This video explains why we’re getting fatter.]( Presumably they mean beyond eating too much… [Must Read]MUST READ [Cancer vaccine could be ready for use by 2030, say BioNTech founders.]( [Cancer vaccine could be ready for use by 2030.]( Uğur Şahin and Özlem Türeci, who are the founders of German company BioNTech, say mRNA [vaccines that can help target cancer]( could be ready for use before the end of this decade. And they’ve got previous when it comes to vaccines, so they might well be right. BioNTech has been working on mRNA technology to develop vaccines since it was founded in 2018. Its portfolio spans influenza and – yes, you guessed it – COVID-19. In fact, before the end of 2020, BioNTech's BNT162b2 candidate had demonstrated 91 percent efficacy in preventing the infection in those vaccinated with two doses. Its vaccines use mRNA, a type of nucleic acid in the cells, to make proteins. And it says the same technology can be used to train the immune cells to identify protein present in cancerous cells and then destroy them. BioNTech already has multiple cancer vaccine candidates in clinical trials and is hopeful that its COVID success will help with its cancer work as well. → Türeci isn't certain that BioNTech will have a cure for cancer, but she is hopeful that breakthroughs made in the area can be used to advance the cause. [READ MORE [Arrow]]( [Facebook]( [INNOVATION]INNOVATION [NASA prepares to break the sound barrier with Lockheed Martin's X-59.]( With the help of NASA's QueSST mission, aeronautical innovators hope to [break the sound barrier again](. The eventual aim is for all of us to be able to fly at speeds equal to or faster than the X-1 pilots who recently went supersonic. [READ MORE [Arrow]]( And Other Stories in Innovation - ‘The hell with it…’ Elon Musk now says SpaceX will [continue to fund Ukraine coverage](. - [No more lithium]( 4 ways renewable energy could be stored in the future. [premium] - Israeli startup's [plant-based salmon]( saves fish population, thanks to 3D printing. [SCIENCE]SCIENCE [6,000-year-old skull confirms legend of indigenous ‘tiny’ people in Taiwan.]( An international team of researchers might have [proved the existence]( of an indigenous population of Austronesian people — whose presence was only recalled from fables and legends — from a cave in Taiwan. [READ MORE [Arrow]]( And Other Stories in Science - What happens if you [grow plants on the Moon]( New study shows how they react. - Large wildfires are [triggering intense dust storms]( closer to populated areas, new study finds. - [The unfair floods of Pakistan]( ‘Climate carnage’ or botched engineering? [premium] [MAIL & MUSINGS]MAIL & MUSINGS Cancer vaccine could be ready for use by 2030, say BioNTech founders. Do you think someone will be able to develop a vaccine to cure cancer one day? [No, there are too many types]( [It would be great but it’s unlikely]( [Yes, anything’s possible]( [It’s hard to say either way]( YESTERDAY'S RESULTS Yesterday, we asked you what you think the main barrier might be to the motionless wind turbine becoming commercially viable, and 38 percent of you said the cost of mass production. ...But opposition from wind turbine manufacturers wasn't far behind with 30 percent, interestingly. 38% The cost of mass production 30% Opposition from wind turbine manufacturers 19% Something else entirely 13% Regulatory issues [QUOTE OF THE DAY]QUOTE OF THE DAY “Ignorance is preferable to error; and he is less remote from the truth who believes nothing, than he who believes what is wrong.” Thomas Jefferson 1743–1826 American Democratic Republican statesman, 3rd President 1801–9: Notes on the State of Virginia (1781–5) Query 6. [THINGS WE LOVE]THINGS WE LOVE [image]( [KINGLEV Magnetic Levitating Platform]( [image]( [Toysmith Voice Changer]( [image]( [GlocalMe U3 WiFi Hotspot]( [image]( [Satechi Multiport Adapter]( [AND ANOTHER THING]AND ANOTHER THING - A small wireless implant could help [kill deadly brain tumors](. - Greenland is disappearing quickly, and scientists have [found a new reason why](. (Scientific American) - A small modification allowed Tesla Model S to travel [1,600 miles without charging](. - [UK isn't prepared]( for the next pandemic, says ex-vaccine chief. (New Scientist) - NASA's gas gun [shoots pellets at 5 miles per second]( to test space shields. - Iraqi minister admits [gas flaring cancer link](. (BBC) - [Could coffee prolong your life?]( Scientists think it might. [premium] [Subscribe to IE+ today.]( Prepared by Alice Cooke Enjoy Reading? Forward this email to a friend. Was this email forwarded to you?[Join Free!]( [About Us]( [Advertise]( [Contact Us]( [Facebook]( [Twitter]( [Youtube]( [Linkedin]( [Instagram]( You are receiving this email because you have subscribed to our newsletter. Manage you e-mail preferences or unsubscribe[here](. © Copyright 2022 | The Blueprint is by Interesting Engineering, Inc. 201 Spear Street, Suite 1100 San Francisco, CA 94105 | All Rights Reserved [Interesting Engineering]